Validation of Beat-to-beat Wavefront Direction Using Omnipolar Mapping

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-18

Study Completion Date

2022-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To validate omnipolar mapping in a well-described circuit within the heart (Atrial Flutter) and compare it with the gold standard of Local Activation Time (LAT) mapping during routine, clinically indicated procedures of Atrial Flutter ablation. A conventional, LAT map will be created during the procedure, prior to treatment, to guide the procedure. A repeat map will be performed after ablation during the procedure. The investigators will export the map files for off-line analysis with the omnipolar software.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ripple Mapping Guided Ablation of Ischaemic Ventricular Tachycardia.

NCT03997201

Ventricular Tachycardia Ischemic Heart Disease

COMPLETED NA

Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along With EnSite Velocity Contact System

NCT01401361

Typical Atrial Flutter

COMPLETED PHASE3

Maximum Targeted Ablation of Atrial Flutter

NCT00491010

Atrial Flutter

UNKNOWN PHASE4

Biatrial Global High-density Electroanatomical Mapping of Atrial Fibrillation

NCT03812601

Atrial Fibrillation

COMPLETED

AcQBlate Force Sensing Ablation System US IDE for Atrial Flutter (AcQForce Flutter)

NCT04658940

Typical Atrial Flutter

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Electroanatomical mapping of the chambers of the heart has revolutionised the way physicians treat heart rhythm disorders. However, there still are technical limitations that prevent us from gathering information that could be used to understand and treat these abnormal circuits in more detail.

The gold standard technique in creating electrical maps of the heart in stable circuits is the Local Activation Time (LAT) map. This map is formed by using a stable electrical point (one of the electrode catheters within the heart - plastic tubes with metallic sensors at the end) as a zero point and then collecting electrical data from around the heart based on timings off of that point. This data is then loaded on a licenced software that creates the map. These maps are very useful in creating electrical maps of the heart in relatively stable electrical circuits and can give us information on how the electrical current travels through the heart tissue. These are widely used in guiding ablation by helping us locate areas to ablate (apply local radiofrequency and burn part of the circuit, deactivating it).

In more unstable circuits, such as in Atrial Fibrillation (chaotic electrical activity at the top left chamber of the heart), there are a lot of limitations of this technology as the electrical current changes from heart beat to heart beat and there is no stable zero point In the circuit to "anchor" the map in time. In these situations real-time map creation with local electrical currents would be ideal as it would help us see the direction the electrical wave front travels in real time. Our current electrical catheters have certain limitations which mainly have to do with difficulty in local electrical discrimination and detection of the orientation of the electrical current in real time.

The Advisor HD Grid catheter by Abbott UK can overcome this hurdle. It has a special electrode configuration (4 by 4) that creates 9 distinct anatomical spaces within the catheter grid that can "triangulate" micro current direction in real time (omnipolar mapping). This will greatly enhance our ability to quickly detect electrical wave fronts in unstable circuits such as Atrial Fibrillation which will lead to better understanding of the arrhythmia and identify targets for treatment quickly and efficiently.

The investigators aim to first validate the robustness of omnipolar mapping in a well-described, stable circuit such as Atrial Flutter, and compare it to the gold standard of LAT mapping. This will then help pave the way for use of this technology in more complex circuits, such as Atrial Fibrillation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Flutter Typical

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Omnipolar Eletroanatomical mapping

Intervention Type DIAGNOSTIC_TEST

Analyse intracardiac EGMs collected with the HD Grid catheter (Abbott, Chicago, IL) during routine Atrial Flutter ablation using the Omnipolar algorithm.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Omnipolar Eletroanatomical mapping

Analyse intracardiac EGMs collected with the HD Grid catheter (Abbott, Chicago, IL) during routine Atrial Flutter ablation using the Omnipolar algorithm.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Eligible patients on the waiting list for radiofrequency ablation of Atrial Flutter at the Hammersmith Hospital, Imperial College Healthcare NHS Trust.

1. Suitable candidate for catheter mapping/ablation of arrhythmias.
2. Eighteen (18) to eighty-five (85) years of age.
3. Body Mass Index (BMI) \<40 (Wt. in Kgs / Ht. in cm).
4. Signed Informed Consent.

Exclusion Criteria

1. Severe cerebrovascular disease
2. Moderate to severe renal impairment (eGFR\<30 ml/min/1.73m2)
3. Active gastrointestinal bleeding.
4. Active infection or fever.
5. Short life expectancy.
6. Significant anaemia.
7. Severe uncontrolled systemic hypertension.
8. Severe electrolyte imbalance.
9. Ejection fraction \<35%.
10. Congestive heart failure (NYHA IV).
11. Unstable angina requiring emergent PTCA (percutaneous transluminal coronary angioplasty) or CABG (Coronary Artery Bypass Grafting).
12. Recent myocardial infarction.
13. Bleeding or clotting disorders.
14. Uncontrolled diabetes.
15. Inability to receive IV or oral Anticoagulants.
16. Unable to give informed consent (these patients would not be recruited).
17. Previous catheter or surgical ablation treatment for Atrial Fibrillation.
18. Previous catheter ablation treatment for Atrial Flutter.
19. Pregnancy (urinary pregnancy test will be offered on the day of the procedure for all women of reproductive age)
20. Drug and/or alcohol abuse.
21. Patients who have participated in another study of an investigational medicinal product in the last 3 months.

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No